Michael M. Yeboah

Biochemistry, Genetics and Molecular BiologyNeuroscienceMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Dual soluble epoxide hydrolase inhibitor/PPAR-γ agonist attenuates renal fibrosis”.

Dual soluble epoxide hydrolase inhibitor/PPAR-γ agonist attenuates renal fibrosis

Prostaglandins & Other Lipid Mediators(2020)10.1016/j.prostaglandins.2020.106472

N/A

0.489DataRank · unranked

25 citations

Abdul H. Khan, Michael M. Yeboah, Marla A. Chesnik, Wojciech K. Jankiewicz, M. Hartmann +6 more

Salt-sensitive hypertension after reversal of unilateral ureteral obstruction

Biochemical Pharmacology(2023)10.1016/j.bcp.2023.115438

N/A

0DataRank · unranked

6 citations

Abdul H. Khan, Anna Stavniichuk, Wojciech K. Jankiewicz, Samaneh Goorani, Michael M. Yeboah +2 more

Dual acting inhibitor of soluble epoxide hydrolase and Cyclooxygenase-2, attenuates glomerular injury in renal hypoplasia mice

European Journal of Pharmacology(2025)10.1016/j.ejphar.2025.178132

N/A

0DataRank · unranked

2 citations

Samaneh Goorani, Anna Atamanchuk, Wojciech K. Jankiewicz, Michael M. Yeboah, Scott D. Barnett +7 more